Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: Detection of extrapulmonary H1N1 RNA and use of intravenous peramivir.
作者信息
Campbell Angela P, Jacob Shevin T, Kuypers Jane, Wald Anna, Englund Janet A, Corey Lawrence, Boeckh Michael
出版信息
Ann Intern Med. 2010 May 4;152(9):619-20. doi: 10.7326/0003-4819-152-9-201005040-00022.
Abstract
摘要
相似文献
1
Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: Detection of extrapulmonary H1N1 RNA and use of intravenous peramivir.一名造血干细胞移植受者因2009年甲型H1N1新型流感导致的呼吸衰竭：肺外H1N1 RNA的检测及静脉注射帕拉米韦的应用
Ann Intern Med. 2010 May 4;152(9):619-20. doi: 10.7326/0003-4819-152-9-201005040-00022.
2
Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir.在接受静脉注射帕拉米韦治疗的造血细胞移植受者中H275Y突变的早期出现。
Transpl Infect Dis. 2010 Dec;12(6):513-7. doi: 10.1111/j.1399-3062.2010.00582.x. Epub 2010 Nov 10.
3
Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.美国紧急 IND 项目中接受静脉滴注帕拉米韦治疗的成人和儿童 2009 年甲型 H1N1 流感的临床经验。
Clin Infect Dis. 2011 Mar 15;52(6):695-706. doi: 10.1093/cid/cir001.
4
Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09.静脉滴注帕拉米韦治疗重症甲型 H1N1 流感。
PLoS One. 2012;7(6):e40261. doi: 10.1371/journal.pone.0040261. Epub 2012 Jun 29.
5
Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice.法匹拉韦和帕拉米韦联合治疗甲型流感病毒/加利福尼亚/04/2009（H1N1）病毒感染的小鼠。
Antiviral Res. 2012 Apr;94(1):103-10. doi: 10.1016/j.antiviral.2012.03.001. Epub 2012 Mar 10.
6
Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts.免疫功能低下宿主治疗过程中对奥司他韦和帕拉米韦耐药的大流行 H1N1 病毒的快速选择。
Clin Infect Dis. 2010 May 1;50(9):1252-5. doi: 10.1086/651605.
7
Oseltamivir-resistant 2009 H1N1 influenza pneumonia during therapy in a renal transplant recipient.一名肾移植受者在治疗期间发生对奥司他韦耐药的2009年甲型H1N1流感肺炎。
Pediatr Transplant. 2012 Aug;16(5):E153-7. doi: 10.1111/j.1399-3046.2011.01489.x. Epub 2011 Mar 9.
8
Intravenous peramivir for treatment of influenza in hospitalized patients.静脉注射帕拉米韦用于住院患者流感的治疗。
Antivir Ther. 2014;19(4):349-61. doi: 10.3851/IMP2680. Epub 2013 Aug 28.
9
Response to several recent publications related to safety and efficacy of peramivir from the emergency use authorization experience.基于紧急使用授权经验对近期几篇有关帕拉米韦安全性和有效性的出版物的回应。
Clin Infect Dis. 2013 Jan;56(1):164. doi: 10.1093/cid/cis800. Epub 2012 Sep 12.
10
Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016.甲型 H1N1pdm09 流感病毒因 H275Y/G147R 双重突变而对奥司他韦和帕拉米韦产生交叉耐药性增强，日本，2016 年 3 月。
Euro Surveill. 2016 Jun 16;21(24). doi: 10.2807/1560-7917.ES.2016.21.24.30258.
引用本文的文献
1
Challenges to the Effectiveness and Immunogenicity of COVID-19 Vaccines: A Narrative Review with a Systematic Approach.新冠疫苗有效性和免疫原性面临的挑战：一项采用系统方法的叙述性综述
Vaccines (Basel). 2025 Jul 24;13(8):789. doi: 10.3390/vaccines13080789.
2
Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses.重新思考针对冠状病毒、流感病毒和其他呼吸道病毒的下一代疫苗。
Cell Host Microbe. 2023 Jan 11;31(1):146-157. doi: 10.1016/j.chom.2022.11.016.
3
Influenza.流感。
Lancet. 2022 Aug 27;400(10353):693-706. doi: 10.1016/S0140-6736(22)00982-5.
4
Clinical Effectiveness and Safety of Antivirals for Influenza in Pregnancy.孕期使用抗流感病毒药物的临床有效性与安全性
Open Forum Infect Dis. 2021 Mar 20;8(6):ofab138. doi: 10.1093/ofid/ofab138. eCollection 2021 Jun.
5
Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management.老年患者移植后病毒性呼吸道感染：流行病学、诊断与管理
Drugs Aging. 2017 Oct;34(10):743-754. doi: 10.1007/s40266-017-0491-5.
6
Influenza prevention and treatment in transplant recipients and immunocompromised hosts.移植受者和免疫功能低下宿主的流感预防和治疗。
Influenza Other Respir Viruses. 2013 Nov;7 Suppl 3(Suppl 3):60-6. doi: 10.1111/irv.12170.
7
Novel antiviral agents for respiratory viral infection in immunocompromised adults.免疫功能低下成人呼吸道病毒感染的新型抗病毒药物。
Curr Infect Dis Rep. 2013 Dec;15(6):497-503. doi: 10.1007/s11908-013-0370-0.
8
Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes.造血细胞移植受者呼吸道合胞病毒下呼吸道疾病：血液中病毒 RNA 的检测、抗病毒治疗和临床结局。
Clin Infect Dis. 2013 Dec;57(12):1731-41. doi: 10.1093/cid/cit639. Epub 2013 Sep 24.
9
Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.金刚烷胺、奥司他韦和利巴韦林联合治疗甲型流感感染：安全性和药代动力学。
Antivir Ther. 2013;18(3):377-86. doi: 10.3851/IMP2475. Epub 2012 Dec 21.
10
Influenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipients.血液中流感病毒 RNA 的检测可作为预测造血细胞移植受者疾病严重程度的标志物。
J Infect Dis. 2012 Dec 15;206(12):1872-7. doi: 10.1093/infdis/jis610. Epub 2012 Oct 2.
本文引用的文献
1
Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT.造血细胞移植（HCT）后呼吸病毒肺炎：支气管肺泡灌洗液样本中病毒载量、血清样本中病毒 RNA 检测与 HCT 临床结局之间的关系。
J Infect Dis. 2010 May 1;201(9):1404-13. doi: 10.1086/651662.
2
How I treat influenza in patients with hematologic malignancies.我如何治疗血液恶性肿瘤患者的流感。
Blood. 2010 Feb 18;115(7):1331-42. doi: 10.1182/blood-2009-11-255455. Epub 2009 Dec 15.
3
H1N1 novel influenza A in pregnant and immunocompromised patients.孕妇和免疫功能低下患者中的 H1N1 新型甲型流感。
Crit Care Med. 2010 Apr;38(4 Suppl):e52-7. doi: 10.1097/CCM.0b013e3181c85d5f.
4
Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses.淋巴细胞减少期间流感病毒的长期感染及耐药病毒的频繁检测。
J Infect Dis. 2009 May 15;199(10):1435-41. doi: 10.1086/598684.
5
Pathology of human influenza revisited.再探人类流感病理学
Vaccine. 2008 Sep 12;26 Suppl 4(Suppl 4):D59-66. doi: 10.1016/j.vaccine.2008.07.025.
Zotero 插件